KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to -$30.5 million.

  • Acadia Pharmaceuticals' Cash from Investing Activities rose 3.77% to -$79.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$124.5 million, marking a year-over-year increase of 18.62%. This contributed to the annual value of -$30.5 million for FY2024, which is 195.44% down from last year.
  • As of FY2024, Acadia Pharmaceuticals' Cash from Investing Activities stood at -$30.5 million, which was down 195.44% from $32.0 million recorded in FY2023.
  • Acadia Pharmaceuticals' 5-year Cash from Investing Activities high stood at $192.5 million for FY2020, and its period low was -$71.1 million during FY2021.
  • Moreover, its 3-year median value for Cash from Investing Activities was $32.0 million (2023), whereas its average is $24.9 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Cash from Investing Activities soared by 216.08% in 2020 and then crashed by 195.44% in 2024.
  • Over the past 5 years, Acadia Pharmaceuticals' Cash from Investing Activities (Yearly) stood at $192.5 million in 2020, then slumped by 136.93% to -$71.1 million in 2021, then soared by 203.01% to $73.2 million in 2022, then crashed by 56.31% to $32.0 million in 2023, then crashed by 195.44% to -$30.5 million in 2024.